about
Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia majorCadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cellsGenetic regulation of cell function in response to iron overload or chelation.Mitochondrial involvement in genetically determined transition metal toxicity I. Iron toxicity.Pleiotropic effects of cadmium in mesangial cells.Multiple roles of cadmium in cell death and survival.Effects of cadmium on the actin cytoskeleton in renal mesangial cells.Interplay of calcium and cadmium in mediating cadmium toxicity.Heparin interaction with a receptor on hyperglycemic dividing cells prevents intracellular hyaluronan synthesis and autophagy responses in models of type 1 diabetes.Iron-dependent turnover of IRP-1/c-aconitase in kidney cells.Cell density-dependent shift in activity of iron regulatory protein 1 (IRP-1)/cytosolic (c-)aconitase.Transport of iron chelators and chelates across MDCK cell monolayers: implications for iron excretion during chelation therapy.Iron-loaded cardiac myocytes stimulate cardiac myofibroblast DNA synthesis.A Northwestern blotting approach for studying iron regulatory element-binding proteins.Suppression of mitogen-activated protein kinase phosphatase-1 (MKP-1) by heparin in vascular smooth muscle cells.Tentative reference values for nickel concentrations in human serum, plasma, blood, and urine: evaluation according to the TRACY protocol.Evaluation of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients.Cadmium-induced glutathionylation of actin occurs through a ROS-independent mechanism: implications for cytoskeletal integrity.Ca(2+)/calmodulin-dependent protein kinase II inhibition by heparin in mesangial cells.Heparin inhibits mitogen-activated protein kinase-dependent and -independent c-fos induction in mesangial cells.Induction of c-fos proto-oncogene in mesangial cells by cadmium.Cadmium-induced aggregation of iron regulatory protein-1.Involvement of CaMK-IIδ and gelsolin in Cd(2+) -dependent cytoskeletal effects in mesangial cells.Interaction of iron regulatory protein-1 (IRP-1) with ATP/ADP maintains a non-IRE-binding state.Low-concentration heparin suppresses ionomycin-activated CAMK-II/EGF receptor- and ERK-mediated signaling in mesangial cells.Role of the cytoskeleton in Cd2+-induced death of mouse mesangial cells.Nickel binding to the C-terminal tryptic fragment of a peptide from human kidney.Cadmium favors F-actin depolymerization in rat renal mesangial cells by site-specific, disulfide-based dimerization of the CAP1 protein.Protective effect of cadmium-induced autophagy in rat renal mesangial cells.Initiation of caspase-independent death in mouse mesangial cells by Cd2+: involvement of p38 kinase and CaMK-II.Cadmium inhibits both intrinsic and extrinsic apoptotic pathways in renal mesangial cells.The basis and applicability of the dimethylmethylene blue binding assay for sulfated glycosaminoglycans.Properties and Units in the Clinical Laboratory Sciences. IX. Properties and Units in Trace Elements (IUPAC-IFCC Technical report 1997). International Union of Pure and Applied Chemistry and International Federation of Clinical Chemistry. rita.corneAbsorption and retention of nickel from drinking water in relation to food intake and nickel sensitivity.Modulation of stellate cell proliferation and gene expression by rat hepatocytes: effect of toxic iron overload.Structure and metabolism of multiple heparan sulphate proteoglycans synthesized by the isolated rat glomerulus.Heparin suppresses lipid raft-mediated signaling and ligand-independent EGF receptor activationGlypicans: a growing trendHistidine at the active centre of pig heart lipoamide dehydrogenaseSpeciation of tissue and cellular iron with on-line detection by inductively coupled plasma-mass spectrometry
P50
Q28279216-27629D6B-B4C5-4C95-807C-CA6B5284A7ADQ28585877-0155EFB2-5EC0-4988-96E5-3C81A877CBADQ35044730-DE16A3A0-C413-42B8-8473-5678A0A0D095Q36517370-660D00EB-D9FE-4CD6-A93E-627A01DE2524Q37398178-8648D777-B579-49CA-984B-6A3E869FA3ECQ37720191-92F25060-07F9-4F4B-A271-42161760DD7EQ38078008-4DAEE65B-EDB3-40FC-BAD9-C4BC4533825FQ38181855-5983BBD9-A70F-4CCC-8D4F-1E506305D81AQ38429256-037D5D13-42E0-4110-A6BB-B18C4BBDD938Q38912921-82211741-A0EF-4C4C-9714-4E42AE25A72CQ39356773-98C821D4-B6BE-4B9F-9B0B-BC0185869382Q39730663-B402A086-F8A5-47C0-A27B-B0C24493B611Q40343543-8F1A9328-938F-40E2-B772-31FAF0C351D5Q40455795-D92EC08B-C401-4EA1-9E40-0A8CE75FD9E3Q40639046-8F5BC547-820C-479E-9E10-744617E4936EQ40670856-B10504C0-BEDB-40BE-A7D2-D2618A198680Q42143168-D1632487-DF57-4F13-845D-72DF50DCC65FQ42441714-6FDD11E1-AA43-4E99-BC51-6757FE0DDB21Q42468026-AB2DE1B5-F90F-46D2-9C65-E53FA75802E4Q42518871-D2425537-8CB3-4230-A0BE-A47B536EE9A8Q42545812-C03BA68F-34C6-4853-8198-D89478070172Q42704540-A074F8CA-AFC3-4CA0-9710-4076976902F7Q42718516-199EFA3B-D01D-4F66-BC63-0DC326B6DB69Q43009519-D9B6E25C-D3D9-4EB4-938E-5FD3DDAB324FQ43078685-B1D330D8-F222-444C-9F69-D49607151E82Q43098985-5E0621C3-7841-49BA-B093-8E378079A040Q45117797-F16B22E7-5C46-49E2-B331-5243A2EA4062Q46244845-9F158EF8-43D3-4D0F-BBAE-F477B26067A7Q46245519-619DD194-FD0E-4E46-B436-720AF911F737Q46572615-F7688BA6-5518-43AC-92BB-2B0E815FB2FFQ46786603-D95CA75C-3B7D-4DE3-9B67-6385B2ADE6BDQ46990051-E8533251-DADA-41DF-A788-8D70B146A281Q49172847-A2365F66-3CD2-4D90-81B5-C7323CB1AB62Q50848906-606F0783-62E8-4FB0-927C-94DB299E6430Q51834811-1EDF9D70-F9AA-4E7F-828D-BD0E5E97481CQ54264297-C5321C1C-2C59-4744-BAEB-A1F6E8DF4B89Q57351509-5F6935CA-0C0C-4F56-A548-0BC650FACE63Q57791371-715E4CB0-49CF-47C0-B6D4-A0B5A877EF26Q66978999-1525A6FD-91D5-42CB-9A13-E150F8BBAE8EQ67586869-23DCE646-EAD1-4427-BADE-03192A53186D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Douglas M. Templeton
@ast
Douglas M. Templeton
@en
Douglas M. Templeton
@es
Douglas M. Templeton
@nl
Douglas M. Templeton
@sl
type
label
Douglas M. Templeton
@ast
Douglas M. Templeton
@en
Douglas M. Templeton
@es
Douglas M. Templeton
@nl
Douglas M. Templeton
@sl
prefLabel
Douglas M. Templeton
@ast
Douglas M. Templeton
@en
Douglas M. Templeton
@es
Douglas M. Templeton
@nl
Douglas M. Templeton
@sl
P106
P1153
7102149305
P21
P31
P496
0000-0003-0693-662X